Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication

被引:20
|
作者
Taskin, Orhun Cig [1 ]
Clarke, Callisia N. [2 ]
Erkan, Mert [3 ,4 ]
Tsai, Susan [2 ]
Evans, Douglas B. [2 ]
Adsay, Volkan [1 ]
机构
[1] Koc Univ Hosp, Dept Pathol, Davutpasa Caddesi 4, TR-34010 Istanbul, Turkey
[2] Med Coll Wisconsin, Dept Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA
[3] Koc Univ Hosp, Dept Surg, Istanbul, Turkey
[4] Koc Univ, Res Ctr Translat Med, Istanbul, Turkey
关键词
Pancreas; neuroendocrine neoplasm; tumor; carcinoma; pathology; terminology; classification; prognosis; WHO; 2019; KI67 PROLIFERATIVE INDEX; CLINICOPATHOLOGICAL ANALYSIS; ENDOCRINE NEOPLASMS; HIGH-GRADE; GASTROENTEROPANCREATIC SYSTEM; CONSENSUS GUIDELINES; LABELING INDEX; CELL-CARCINOMA; TUMORS; EXPRESSION;
D O I
10.21037/jgo.2020.03.07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Significant improvements have taken place in our understanding of classification neuroendocrine neoplasms of the pancreas in the past decade. "These are now regarded in three entirely separate categories: (I) neuroendocrine tumors (PanNETs) are by definition well differentiated, the pancreatic counterpart of carcinoids; (II) neuroendocrine carcinomas, which are poorly differentiated (PDNEC), the pancreatic examples of small cell carcinomas or large cell neuroendocrine carcinomas; (III) other neoplasms that have neuroendocrine differentiation or a distinct neuroendocrine component. PanNETs are by far the most common. They are now regarded as malignancies (albeit often curable when low grade and low stage) with the exception of minute incidental proliferations (tumorlets, or dysplastic-like changes) seen in the setting of some syndromes like MEN. PanNETs are staged based on their size, and for small T1 tumors, watchful waiting is now being considered, although these tumors are also known to show about 10% metastatic rate and/or progression, creating concerns about this approach. PanNETs are graded into 3, based on the proliferative activity, mostly based on the Ki-67 index, and also partly mitotic activity, although the latter seldom if ever is the determinant of the final grade. Neuroendocrine neoplasms with well differentiated morphology but Ki-67 >20% are now regarded as Pa.nNFT Grade 3 (G3); they have been shown to have a prognosis significantly worse than lesser grade PanNETs but still incomparably better than frank PDNECs, the latter typically has Ki-67 >50% (often much higher) and require platinum-based chemotherapy. There are also cases that are ambiguous between PanNET-G3 and PDNEC, and very rarely transformation of the former to the latter appears to occur. For low grade (G 1/G2) PanNETs, more refined criteria to further prognosticate this group are needed. Morphologic variants being recognized may bring new perspectives to this group.
引用
收藏
页码:548 / 558
页数:11
相关论文
共 50 条
  • [31] New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification [1]
    Wang, Min
    Ding, Ding
    Qin, Tingting
    Wang, Hebin
    Liu, Yahui
    Liu, Jianhua
    Liu, Jun
    Zhang, Hang
    Zhao, Junfang
    Wu, Chien-Hui
    Javed, Ammar
    Wolfgang, Christopher
    Guo, Shiwei
    Chen, Qingmin
    Zhao, Weihong
    Shi, Wei
    Zhu, Feng
    Guo, Xingjun
    Li, Xu
    He, Ruizhi
    Xu, Simiao
    Edil, Barish
    Tien, Yu-Wen
    Jin, Gang
    Zheng, Lei
    He, Jin
    Qin, Renyi
    CANCER LETTERS, 2021, 518 : 207 - 213
  • [32] Challenges in the Classification of High-Grade Neuroendocrine Neoplasms Based on Current Recommendations
    Joseph, Nancy
    Kim, Grace
    Umetsu, Sarah
    Kakar, Sanjay
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 1046 - 1046
  • [33] Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) - Update and new WHO Classification 2017 for pancreatic neuroendocrine neoplasia
    Brcic I.
    Journal für Klinische Endokrinologie und Stoffwechsel, 2017, 10 (4): : 122 - 124
  • [34] Challenges in the Classification of High-Grade Neuroendocrine Neoplasms Based on Current Recommendations
    Joseph, Nancy
    Kim, Grace
    Umetsu, Sarah
    Kakar, Sanjay
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1046 - 1046
  • [35] Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment
    Shariq, Omair A.
    McKenzie, Travis J.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [36] Pancreatic Neuroendocrine Neoplasms: Classification and Novel Role of Endoscopic Ultrasound in Diagnosis and Treatment Personalization
    Tacelli, Matteo
    Partelli, Stefano
    Falconi, Massimo
    Arcidiacono, Paolo Giorgio
    Capurso, Gabriele
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2025, 13 (01) : 34 - 43
  • [37] Anatomic variations of the spleen: current state of terminology, classification, and embryological background
    Ivan Varga
    Jozef Babala
    David Kachlik
    Surgical and Radiologic Anatomy, 2018, 40 : 21 - 29
  • [38] Anatomic variations of the spleen: current state of terminology, classification, and embryological background
    Varga, Ivan
    Babala, Jozef
    Kachlik, David
    SURGICAL AND RADIOLOGIC ANATOMY, 2018, 40 (01) : 21 - 29
  • [39] Chirurgie bei neuroendokrinen Neoplasien des Pankreas: State of the ArtSurgery of pancreatic neuroendocrine neoplasms: state of the art
    A. Nießen
    S. Schimmack
    F. Billmann
    T. Hackert
    Die Chirurgie, 2022, 93 (8) : 745 - 750
  • [40] A Clinicopathologic and Molecular Update of Pancreatic Neuroendocrine Neoplasms With a Focus on the New World Health Organization Classification
    Fang, Jiayun M.
    Shi, Jiaqi
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (11) : 1317 - 1326